Ross is a partner in the Corporate Technology team, based in our Cambridge office.

Ross’s practice focuses on helping tech and life sciences companies in all aspects of their growth, capital raising and international expansion. He has extensive experience of a variety of venture financing and public capital raisings, mergers and acquisitions and general corporate advice, with a particular specialism in transactions with a transatlantic component.

Ross has extensive experience of transactions involving the US and was based out of San Francisco, CA in 2018 - 19. As a result, he has a particular expertise in supporting US investors and companies in their investment into the UK and elsewhere, as well as counselling UK companies looking to take investment from, or exit to, the US. He is an English qualified solicitor and registered foreign legal consultant in California.

Ross is the co-author of PLC’s leading article on M&A pricing structures: Pricing Mechanisms: locked box vs completion accounts.

Show full CV Hide full CV

Latest news & insights

Life sciences & healthcare

Biologics and biosimilars litigation update

7 August 2020
QUICK READ

by Matthew Royle, Ph.D.

Click here to find out more
robotic-arm
Brexit

Brexit readiness for overseas medical devices manufacturers: trade marks

6 August 2020
QUICK READ

by multiple authors

Click here to find out more
DNA helix
Life sciences & healthcare

Paul England writes on COVID-19 drug supply and patent system for Manufacturing Chemist

6 August 2020
QUICK READ

by Paul England, DPhil

Click here to find out more
Life sciences & healthcare

Return to work: key issues for life sciences

4 August 2020
QUICK READ

by Helen Farr and Adrian Toutoungi

Click here to find out more

Related people

Meet me at

There are no upcoming events